MetaADEDB 2.0 @ LMMD
erythromycin stearate
(YAVZHCFFUATPRK-YZPBMOCRSA-N)
Structure
SMILES
CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@@H]2O[C@@H](C)[C@@H]([C@](C2)(C)OC)O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C[C@H](C(=O)[C@@H]([C@H]([C@]1(C)O)O)C)C)(C)O.CCCCCCCCCCCCCCCCCC(=O)O
Molecular Formula:
C55H103NO15
Molecular Weight:
1018.400
Log P:
8.1181
Hydrogen Bond Acceptor:
16
Hydrogen Bond Donor:
6
TPSA:
231.21
CAS Number(s):
643-22-1
Synonym(s)
1.
erythromycin stearate
2.
gallimycin
External Link(s)
MeSHC011462
PubChem Compound5284394
12559
ChEBI34742
CHEMBLCHEMBL1200510
KEGGdr:D02184
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NauseaFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
2DeafnessFAERS: 5US FAERS
3OtotoxicityFAERS: 4US FAERS
4jaundiceFAERS: 3US FAERS
5HypersensitivityFAERS: 2US FAERS
6Medication residue presentFAERS: 2US FAERS
7Product quality issueFAERS: 2US FAERS
8Abdominal PainFAERS: 1US FAERS
9Blood glucose increasedFAERS: 1US FAERS
10Chest PainFAERS: 1US FAERS
11DizzinessFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
12DysgeusiaFAERS: 1US FAERS
13Gastric infectionFAERS: 1US FAERS
14Lip swellingFAERS: 1US FAERS
15Medication ErrorFAERS: 1US FAERS
16NeuralgiaFAERS: 1US FAERS
17OligohydramniosFAERS: 1US FAERS
18Oropharyngeal painFAERS: 1US FAERS
19PancreatitisFAERS: 1US FAERS
20Pruritus allergicFAERS: 1US FAERS
21Pyloric StenosisFAERS: 1US FAERS
22TinnitusFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
23UlcerFAERS: 1US FAERS
24Urinary IncontinenceFAERS: 1US FAERS
25VomitingFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
26DyspepsiaCanada Vigilance: 1Canada Vigilance
27Pneumonia, Bacterial7819942CTD
28UrticariaCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.